When planning for end-of-life care, disease-specific advance care planning delivers greater patient satisfaction and clarity about preferences.
Features
Zoledronic acid is a third-generation bisphosphonate prescribed to reduce pain from bony metastases, treat hypercalcemia of malignancy, and manage osteolytic lesions in multiple myeloma.
In a case like Susie’s, nurses wonder if there was a way to change not the outcome, but the way she died.
Centralized telephone medical management, with automated symptom monitoring and a long distance reach, improved cancer patients’ pain and depression.
Depression accompanies the disease in some people with cancer; in some depression may even predict outcome.
Doxorubicin is an anthracycline antibiotic that is used to treat lymphoblastic and acute myeloblastic leukemias, several types of cancer, Kaposi sarcoma related to AIDS, malignant lymphoma, soft tissue and osteogenic sarcomas, and Wilms tumor.
External irradiation modalities can maximize radiation doses to tumor tissue while minimizing radiation dose to healthy tissues.
Studies show that alternate dosages of fulvestrant may be efficacious, and adverse effects are similar in all regimens.
Developing an evidence-based oral care policy may help to prevent or to more effectively manage oral mucositis in oncology patients.
The advisor forum answers questions about peripheral neuropathy, specialty pharmacies, fatigue following breast cancer treatment, and more.